Insider · CIK 0001608936
Jacob Chacko
Files at FDMT (4D Molecular Therapeutics, Inc.), ORIC (Oric Pharmaceuticals, Inc.). First filing Dec 17, 2024, latest Dec 17, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ORIC: Oric Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Oric Pharmaceuticals, Inc. | $204k 24,660 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | FDMT 4D Molecular Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +22,500 | $0.00 | $0 | 22,500 | Jun 20, 2025 |
| Jan 2, 2025 | ORIC Oric Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Jan 3, 2025 |
| Jan 2, 2025 | ORIC Oric Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitderivative | +100,000 | $0.00 | $0 | 100,000 | Jan 3, 2025 |
| Dec 15, 2024 | ORIC Oric Pharmaceuticals, Inc. | MOption exercise Common Stock | +67,000 | $0.00 | $0 | 803,308 | Dec 17, 2024 |
| Dec 16, 2024 | ORIC Oric Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -24,660 | $8.28 | $204k | 778,648 | Dec 17, 2024 |
| Dec 15, 2024 | ORIC Oric Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -16,667 | $0.00 | $0 | 0 | Dec 17, 2024 |
| Dec 15, 2024 | ORIC Oric Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -22,000 | $0.00 | $0 | 22,000 | Dec 17, 2024 |
| Dec 15, 2024 | ORIC Oric Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -28,333 | $0.00 | $0 | 56,667 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.